Related Experiment Video
Updated: Aug 19, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Thoracic organ transplantation in the United States, 1994-2003
Mark L Barr1, Robert C Bourge, Jonathan B Orens
1University of Southern California, Los Angeles, CA, USA. mbarr@surgery.usc.edu
Insights
Thoracic organ transplantation shows mixed trends. Heart transplant wait times increased, but death rates declined. Lung transplant waiting lists grew, yet survival rates improved, prompting a new allocation system to reduce waitlist deaths.
Area of Science:
- Medicine
- Transplantation Surgery
- Public Health
Background:
- Thoracic organ transplantation is a critical treatment for end-stage organ failure.
- The Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) provide vital data on transplantation outcomes.
- Understanding trends in waiting lists and survival rates is crucial for improving patient management and allocation policies.
Purpose of the Study:
- To review the state of thoracic organ transplantation in 2003 and the preceding decade using OPTN/SRTR data.
- To analyze trends in waiting list duration, patient survival, and organ allocation policies for heart, lung, and heart-lung transplants.
- To evaluate the impact of these trends on patient outcomes and identify areas for policy improvement.
Main Methods:
- Analysis of OPTN/SRTR data from 1994 to 2003.
- Review of waiting list statistics, including patient numbers and time to transplantation.
- Examination of patient survival rates post-transplantation and trends in waiting list mortality.
- Assessment of changes in organ allocation policies, including the introduction of a new lung allocation system.
Main Results:
- Significant increase in time spent on the heart transplant waiting list, with over 49% waiting more than two years by 2003.
- General decline in heart waiting list death rates over the decade.
- Record high for the lung transplant waiting list in 2003 (3,836 registrants), more than tripling since 1994.
- Statistically significant improvement in one-year patient survival for lung recipients in 2002 (82%) compared to 2001 (78%).
- Declining numbers for heart-lung transplant waiting lists, but adjusted patient survival remains worse than for isolated lung recipients, particularly for those with congenital heart disease.
Conclusions:
- The landscape of thoracic organ transplantation has evolved, with increasing wait times for heart transplants but improved survival rates.
- The lung transplant waiting list has expanded significantly, necessitating policy changes to optimize organ allocation and reduce mortality.
- A new lung allocation system, implemented in 2004, aims to prioritize patients based on survival benefit and urgency, addressing the goal of minimizing deaths on the waiting list.
Abstract:
Using OPTN/SRTR data, this article reviews the state of thoracic organ transplantation in 2003 and the previous decade. Time spent on the heart waiting list has increased significantly over the last decade. The percentage of patients awaiting heart transplantation for >2 years increased from 23% in 1994 to 49% by 2003. However, there has been a general decline in heart waiting list death rates over the decade. In 2003, the lung transplant waiting list reached a record high of 3,836 registrants, up slightly from 2002 and more than threefold since 1994. One-year patient survival for those receiving lungs in 2002 was 82%, a statistically significant improvement from 2001 (78%). The number of patients awaiting a heart-lung transplant, declining since 1998, reached 189 in 2003. Adjusted patient survival for heart-lung recipients is consistently worse than the corresponding rate for isolated lung recipients, primarily due to worse outcomes for heart-lung recipients with congenital heart disease. A new lung allocation system, approved in June 2004, derives from the survival benefit of transplantation with consideration of urgency based on waiting list survival, instead of being based solely on waiting time. A goal of the policy is to minimize deaths on the waiting list.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

